Mixed Hyperbilirubinemia

Overview


Plain-Language Overview

Mixed hyperbilirubinemia is a condition where there is an increase in both direct (conjugated) and indirect (unconjugated) bilirubin in the blood. Bilirubin is a yellow pigment produced when the body breaks down old red blood cells, and it is normally processed by the liver before being excreted. When this process is disrupted, bilirubin builds up, causing jaundice, which is a yellowing of the skin and eyes. This condition affects the liver and bile system, impacting how the body removes waste products. Mixed hyperbilirubinemia can signal underlying problems such as liver disease, bile duct obstruction, or hemolysis. It is important because it reflects a combination of issues with bilirubin production and clearance, which can affect overall health.

Clinical Definition

Mixed hyperbilirubinemia is defined as an elevation of both conjugated (direct) and unconjugated (indirect) bilirubin fractions in the serum, indicating a combination of hepatocellular dysfunction and impaired bilirubin clearance or increased bilirubin production. The core pathology involves simultaneous impaired hepatic conjugation or excretion and excessive bilirubin production or impaired uptake. Common causes include hepatitis, cirrhosis, biliary obstruction, and hemolytic anemias. This condition is clinically significant as it often reflects complex liver or hematologic disease processes that require thorough evaluation. The presence of mixed hyperbilirubinemia suggests both intrahepatic cholestasis and hemolysis or impaired bilirubin metabolism. It is a key diagnostic clue in differentiating types of jaundice and guiding further workup.

Inciting Event

Locked content

Latency Period

Locked content

Diagnostic Delay

Locked content

Clinical Presentation


Signs & Symptoms

Locked content

History of Present Illness

Locked content

Past Medical History

Locked content

Family History

Locked content

Physical Exam Findings

Locked content

Diagnostic Workup


Diagnostic Criteria

Locked content

Pathophysiology


Key Mechanisms

Locked content

Organs

Locked content

Tissues

Locked content

Cells

Locked content

Chemical Mediators

Locked content

Treatments


Pharmacological Treatments

Locked content

Non-pharmacological Treatments

Locked content

Prevention


Pharmacological Prevention

Locked content

Non-pharmacological Prevention

Locked content

Outcome & Complications


Complications

Locked content

Short-term Sequelae

Locked content

Long-term Sequelae

Locked content

Differential Diagnoses


Differentials

Locked content

Medical Disclaimer: The content on this site is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. If you think you may be experiencing a medical emergency, call 911 or your local emergency number immediately. Always consult a licensed healthcare professional with questions about a medical condition.

Artificial Intelligence Use: Portions of this site’s content were generated or assisted by AI and reviewed by Erik Romano, MD; however, errors or omissions may occur.

USMLE® is a registered trademark of the Federation of State Medical Boards (FSMB) and the National Board of Medical Examiners (NBME). Doctogenic and Roscoe & Romano are not affiliated with, sponsored by, or endorsed by the USMLE, FSMB, or NBME. Neither FSMB nor NBME has reviewed or approved this content. "USMLE Step 1" and "USMLE Step 2 CK" are used only to identify the relevant examinations.